Status:
NOT_YET_RECRUITING
Sugammadex Reduces Antiemetic Effect of Dexamethasone
Lead Sponsor:
Augusta University
Conditions:
PONV
Eligibility:
All Genders
18+ years
Brief Summary
Sugammadex is a medication used for reversal of muscle relaxation during procedures under general anesthesia. It works by encapsulating muscle relaxant molecules with a steroid ring in its structure. ...
Detailed Description
The study will use de-identified retrospective data to conduct a cross-sectional study to determine the effect of sugammadex on the antiemetic efficacy of dexamethasone in elective adult surgical pati...
Eligibility Criteria
Inclusion
- Older than 18 years old
- Elective surgery
- ASA 1, 2, 3
- At least one risk factor for PONV
Exclusion
- Pregnancy
- Receiving antiemetics prior to arrival to preoperative holding area
- Receiving opioids prior to arrival to preoperative holding area
- Admission to ICU
- Altered mental status
- Rapid sequence induction
- Nausea or vomiting before surgery
Key Trial Info
Start Date :
April 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 15 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06901596
Start Date
April 1 2025
End Date
July 15 2025
Last Update
March 30 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.